Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24492,1000,0.87 [0.75-1.02],0.0887546594793457
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24402,195,0.83 [0.59-1.16],0.2781543293153456
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26445,193,0.80 [0.57-1.12],0.1948048370859271
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18675,774,0.56 [0.47-0.67],6.841970783564466e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26376,124,0.80 [0.53-1.22],0.3076256533806013
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25291,81,1.08 [0.63-1.83],0.790247580742738
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27839,123,0.80 [0.52-1.21],0.2822171421105557
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27833,83,0.77 [0.46-1.27],0.3018106002138029
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24659,66,0.87 [0.49-1.56],0.6483797213093468
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27149,119,1.08 [0.70-1.67],0.7328352411811132
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27098,68,1.24 [0.69-2.22],0.4665662075559669
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27919,78,1.10 [0.64-1.90],0.7190284025681004
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27882,102,1.11 [0.69-1.77],0.6768285446466951
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27877,97,0.95 [0.59-1.54],0.8367518038557394
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,27532,64,0.66 [0.37-1.16],0.1506164296140442
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26704,443,0.84 [0.67-1.06],0.1423031125610118
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26392,131,0.85 [0.56-1.28],0.4288899852626346
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26569,308,0.86 [0.65-1.12],0.2625667011065568
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22853,51,0.66 [0.35-1.25],0.2045604904443203
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22866,64,nan [nan-nan],
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23062,260,nan [nan-nan],
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23070,268,0.91 [0.67-1.24],0.5549688560557311
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23480,678,1.04 [0.87-1.25],0.6637365646854488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22852,50,2.04 [1.05-3.97],0.0349011566390075
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25033,1044,0.96 [0.82-1.11],0.5693412291340838
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26831,296,0.94 [0.72-1.24],0.6602818631113345
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27575,109,1.42 [0.90-2.22],0.1309160195357175
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28013,91,0.84 [0.51-1.36],0.4740175765640873
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Rectum,27792,60,0.54 [0.30-0.94],0.0298854630565162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28012,69,0.63 [0.36-1.08],0.094738968933384
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Stomach,28060,54,0.62 [0.34-1.15],0.1317393674518996
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm,27833,278,1.35 [1.02-1.80],0.0389924462862382
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28007,111,1.77 [1.13-2.79],0.0128879777208544
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28008,107,0.98 [0.62-1.56],0.9474169101397356
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27940,71,1.30 [0.74-2.29],0.3663867659093757
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma, any site",27942,70,1.34 [0.76-2.37],0.3167698915543112
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi,27843,268,1.13 [0.84-1.52],0.4096378005996905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28018,120,1.01 [0.65-1.56],0.9614008455432118
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Other benign neoplasms of skin,27908,232,1.07 [0.78-1.46],0.6798551287118872
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of breast,28000,138,1.26 [0.84-1.89],0.2662381458250248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Leiomyoma of uterus,27481,1012,1.08 [0.93-1.26],0.3145270239281635
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26628,274,0.83 [0.62-1.11],0.2037910746920859
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26353,458,1.01 [0.81-1.26],0.9265779948505548
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26353,458,1.01 [0.81-1.26],0.9265779948505548
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24785,419,0.86 [0.68-1.08],0.1905767226558826
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27484,98,1.28 [0.79-2.08],0.3241710892135472
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27701,107,0.64 [0.41-1.00],0.0494184456531419
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23269,931,0.59 [0.51-0.69],1.0474637218120724e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25691,915,1.07 [0.91-1.26],0.388988555090792
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26179,122,0.95 [0.62-1.47],0.8319046908584611
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27030,61,0.55 [0.31-0.97],0.0387374076271274
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26166,109,0.93 [0.59-1.47],0.7679097605219262
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26477,420,0.40 [0.32-0.50],3.916242002523897e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26468,411,0.39 [0.31-0.49],1.7331916198617227e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25936,199,0.70 [0.48-1.00],0.0496705973665798
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25939,196,0.68 [0.47-0.98],0.0389720965896502
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23072,734,0.60 [0.50-0.71],1.406039235899201e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22421,83,1.00 [0.59-1.68],0.9912722362739034
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,23019,681,0.57 [0.48-0.69],2.9013141677123724e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22389,51,0.66 [0.34-1.27],0.2119860128534387
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22409,71,0.54 [0.31-0.92],0.0233578852154414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,23652,630,0.73 [0.60-0.88],0.0011869515537262
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23141,119,0.90 [0.58-1.39],0.6303703501311025
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27812,79,1.11 [0.66-1.87],0.6821688183664198
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27855,47,0.91 [0.47-1.77],0.7837421411764758
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26585,38,1.25 [0.58-2.68],0.5708397281536528
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28008,38,1.30 [0.61-2.75],0.4965991895372351
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23060,38,1.19 [0.55-2.55],0.6646426914064514
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Alcohol dependence,26571,24,1.26 [0.49-3.25],0.6345699977871747
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,26465,36,0.56 [0.27-1.18],0.1287753024132936
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23065,43,0.58 [0.29-1.17],0.1288063854781368
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23413,391,0.74 [0.58-0.95],0.0162921058443366
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Depression,26014,348,0.75 [0.58-0.96],0.0230078402624651
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Depression or dysthymia,23192,306,0.72 [0.55-0.94],0.015448872095365
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23174,152,0.75 [0.51-1.10],0.1353436713719738
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Other anxiety disorders,26102,77,1.03 [0.61-1.77],0.9029004839161768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,24178,1664,0.76 [0.67-0.85],5.204743577596495e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22106,186,0.73 [0.52-1.04],0.0807720188461374
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27859,154,0.75 [0.52-1.09],0.1358648053472372
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26688,432,0.82 [0.65-1.02],0.0799410860115481
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Epilepsy,26397,141,0.84 [0.56-1.24],0.3803313060825565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Migraine,26387,131,0.95 [0.63-1.43],0.7999751820989164
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27606,121,0.88 [0.57-1.34],0.5450159435061774
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27345,60,0.68 [0.38-1.22],0.1994362942062363
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,26354,98,0.71 [0.44-1.13],0.1502718524329908
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,27630,69,0.80 [0.46-1.40],0.4383849578130605
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26649,877,0.82 [0.70-0.97],0.0188851661698608
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25896,124,0.68 [0.45-1.03],0.0715463915726586
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26332,560,0.84 [0.69-1.03],0.0998661793709076
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27793,76,0.77 [0.45-1.32],0.3426325248976415
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hemiplegia,27774,57,0.86 [0.46-1.60],0.6285521286668836
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,27562,126,0.75 [0.50-1.14],0.1753097437625513
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27309,433,0.84 [0.67-1.05],0.1244176058007815
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27131,255,0.80 [0.60-1.08],0.143409637697605
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26949,73,0.74 [0.43-1.28],0.286766171302702
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27014,138,1.09 [0.73-1.63],0.6771313015681792
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26982,106,0.83 [0.52-1.30],0.4123233854482733
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23846,182,0.72 [0.51-1.02],0.0658530873873529
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,24083,419,0.86 [0.68-1.08],0.1947751481544777
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26997,185,0.97 [0.68-1.37],0.86175502983555
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27787,34,0.93 [0.41-2.07],0.8499301182448039
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1809,34,1.53 [0.71-3.32],0.2821170412458929
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26012,34,0.87 [0.39-1.95],0.7394180912516487
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27335,91,0.84 [0.51-1.37],0.4839716130411281
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27296,52,0.93 [0.48-1.79],0.8236601762143114
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27201,97,1.15 [0.71-1.87],0.5647461603945845
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27471,106,1.01 [0.64-1.60],0.9705216867940636
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27932,132,1.17 [0.78-1.77],0.4485603640125567
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27243,105,0.88 [0.55-1.39],0.5789923864554414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20640,2843,0.69 [0.62-0.76],2.5949719137508426e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27470,75,1.28 [0.74-2.23],0.3760668978629693
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21681,2093,0.62 [0.55-0.69],6.77633246896399e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,21703,2115,0.62 [0.55-0.69],3.3997716006847216e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19638,50,0.45 [0.24-0.87],0.0168328256390529
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26346,739,0.76 [0.63-0.90],0.0017579994926233
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,26120,513,0.76 [0.61-0.93],0.0086282999737514
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27380,152,0.79 [0.54-1.15],0.2186537398702788
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27459,231,0.86 [0.63-1.17],0.3309342342991381
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27989,28,1.51 [0.63-3.62],0.3611424526473199
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25704,97,1.18 [0.73-1.90],0.5034617095718061
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26081,486,0.67 [0.54-0.83],0.0002806705370342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27254,100,1.18 [0.73-1.89],0.5023834341112984
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27356,221,1.11 [0.81-1.53],0.5170780491920586
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27251,97,0.97 [0.60-1.58],0.9145206616794612
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27251,97,0.97 [0.60-1.58],0.9145206616794612
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19683,95,0.85 [0.52-1.39],0.5171374856168467
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24376,40,0.64 [0.31-1.34],0.2353229042932383
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,24416,80,0.75 [0.44-1.26],0.2715098756357261
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16833,105,1.19 [0.73-1.92],0.4823829106147186
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17010,282,0.93 [0.69-1.25],0.639049991202433
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arrhythmias,24386,50,1.24 [0.63-2.44],0.5349765499765062
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24393,57,0.96 [0.51-1.81],0.9049748835269282
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27200,102,0.73 [0.46-1.15],0.1752608182733058
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27258,129,0.95 [0.63-1.44],0.817268340243531
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27300,97,1.02 [0.63-1.65],0.937483317698932
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27370,85,1.00 [0.60-1.67],0.9849541853883488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27055,72,0.65 [0.38-1.11],0.1129161361964376
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27099,116,0.64 [0.42-0.98],0.0414443577568061
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26408,135,1.10 [0.73-1.65],0.6623433843804056
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26381,108,1.08 [0.68-1.70],0.7470598013505827
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27844,105,1.05 [0.67-1.67],0.8215328079541494
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,26891,618,1.09 [0.90-1.33],0.3755613903748016
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,26898,95,0.83 [0.51-1.34],0.4414656041533338
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22793,2136,0.77 [0.69-0.86],2.510810672611788e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27842,130,0.82 [0.54-1.24],0.3417897548157853
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26381,200,0.68 [0.49-0.95],0.0237647789637632
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26362,181,0.71 [0.50-1.01],0.0534778952056799
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27136,233,0.83 [0.61-1.12],0.2262297769940127
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27128,225,0.85 [0.62-1.16],0.3086246675765945
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27275,571,0.99 [0.81-1.21],0.9006157236916402
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic sinusitis,26818,114,0.93 [0.59-1.44],0.7318505332512149
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Nasal polyp,26787,83,1.09 [0.64-1.83],0.7558273132787787
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27064,360,1.04 [0.81-1.33],0.7658531649097573
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,26846,142,1.21 [0.81-1.80],0.3553594200370547
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13517,65,0.75 [0.41-1.38],0.3587127155842807
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25041,1186,0.70 [0.61-0.81],9.424671540646732e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,26972,161,0.56 [0.39-0.80],0.0013803205203243
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26992,181,0.61 [0.44-0.86],0.0044309558526814
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26992,181,0.61 [0.44-0.86],0.0044309558526814
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25962,1020,0.74 [0.64-0.86],7.728492426535071e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Asthma,20839,1020,0.66 [0.57-0.78],2.1436782890959646e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20645,1020,0.66 [0.57-0.77],1.897777013658711e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20824,1005,0.66 [0.57-0.78],2.401241911471072e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27726,83,0.39 [0.25-0.61],4.954663878557668e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,26230,62,0.33 [0.20-0.57],5.203024568001166e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27802,62,0.36 [0.22-0.60],8.628611437489234e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26223,55,0.34 [0.19-0.60],0.0002006142898719
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,26176,89,1.41 [0.85-2.34],0.1854206968474303
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,26283,196,1.25 [0.89-1.76],0.1948442823454598
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26868,94,1.51 [0.92-2.46],0.1013191806534245
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19410,6113,0.82 [0.76-0.89],3.194323847178212e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27477,482,0.96 [0.77-1.19],0.6802858312841202
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28014,108,1.29 [0.81-2.05],0.2774384165625834
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impacted teeth,28019,97,1.18 [0.72-1.92],0.5109332059712004
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,27102,107,0.86 [0.55-1.36],0.5221865860575878
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27116,121,1.07 [0.70-1.65],0.7581195760819168
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28004,119,1.12 [0.72-1.74],0.6168401228964531
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27113,118,0.87 [0.57-1.34],0.5295980179269713
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26807,80,1.11 [0.65-1.89],0.6953242253065937
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27918,50,1.33 [0.68-2.60],0.4068630694987293
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21198,224,0.58 [0.43-0.79],0.0004675192631624
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23331,2357,0.81 [0.73-0.90],9.214834948207072e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophagitis,21266,292,0.78 [0.59-1.03],0.0763296660256841
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21730,756,0.83 [0.69-0.98],0.0326945551521798
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21053,79,1.00 [0.59-1.71],0.9964181262072226
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21110,136,0.81 [0.54-1.22],0.3165586627879876
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21015,41,0.66 [0.32-1.37],0.2665075971173415
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,21122,148,0.60 [0.41-0.87],0.0076744635514884
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Duodenal ulcer,21051,77,0.57 [0.34-0.95],0.0312385790531799
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27968,55,0.70 [0.38-1.29],0.2542765044972044
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic gastritis,21111,137,0.82 [0.55-1.23],0.343458657674809
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21836,862,0.76 [0.64-0.89],0.0008013639391127
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of appendix,27888,148,1.21 [0.81-1.79],0.3477466180738099
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,21560,586,0.96 [0.79-1.18],0.7214916800835245
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21155,181,0.57 [0.41-0.80],0.0013033658883808
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27927,145,1.30 [0.88-1.93],0.1918201128782347
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute appendicitis,27859,119,1.16 [0.75-1.79],0.5178158792327052
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,25116,1223,0.77 [0.67-0.88],0.0001545451950815
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,23962,69,0.87 [0.50-1.54],0.6388564386983431
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Umbilical hernia,23967,74,0.72 [0.42-1.25],0.2408176007584698
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ventral hernia,24003,110,0.69 [0.45-1.08],0.1023008670619178
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24871,978,0.77 [0.66-0.89],0.0006532247364571
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26949,924,0.85 [0.72-0.99],0.0377863654421455
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,22214,2232,0.86 [0.78-0.96],0.0067782246603517
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27702,64,0.48 [0.27-0.83],0.0085838609657857
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27985,93,0.39 [0.25-0.61],3.285159886520531e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,26118,93,0.39 [0.25-0.61],2.8630237224851425e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26093,68,0.49 [0.29-0.84],0.0098119004858811
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27906,134,0.67 [0.45-1.00],0.0487409699877244
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,26159,134,0.66 [0.44-0.99],0.0425298149220503
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26145,120,0.61 [0.40-0.93],0.020195281752665
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26807,782,0.89 [0.75-1.05],0.1752875264792948
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26796,771,0.89 [0.75-1.06],0.2065108352542762
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20089,107,0.69 [0.44-1.08],0.1069835554550674
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal stricture,27572,107,0.74 [0.47-1.15],0.1820315907263734
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20048,66,0.63 [0.36-1.10],0.1059870321359999
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20663,681,0.64 [0.53-0.77],2.4100269009478e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20232,250,0.74 [0.55-0.99],0.0446986522340222
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20382,400,0.79 [0.62-1.00],0.0493727387913134
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,26310,356,0.86 [0.67-1.11],0.2464656360279128
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27530,126,1.02 [0.67-1.55],0.928425818449524
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,20109,127,1.65 [1.08-2.52],0.02050280731712
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,20030,48,0.94 [0.48-1.85],0.8565082486654677
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20889,907,0.90 [0.76-1.05],0.1824752408222361
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,20220,238,1.15 [0.84-1.56],0.3916864115914822
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27512,108,1.13 [0.72-1.79],0.5874445335183853
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,27250,107,0.48 [0.32-0.73],0.0006623323911841
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of liver,27197,54,0.99 [0.52-1.88],0.9755596812025684
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26449,898,0.78 [0.67-0.92],0.0024115861476602
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholelithiasis,26301,750,0.81 [0.68-0.96],0.0146771191491659
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholecystitis,25687,136,0.73 [0.49-1.08],0.1131261785896086
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25622,71,0.64 [0.37-1.11],0.1108544798713499
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis,25614,63,0.79 [0.44-1.41],0.4208247761606366
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27894,63,0.80 [0.45-1.44],0.4631899854325778
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26637,312,0.76 [0.59-0.99],0.0451042003574408
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26431,106,0.85 [0.54-1.35],0.4959000927716246
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Coeliac disease,26415,90,0.75 [0.46-1.23],0.2581442596813683
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26365,40,1.40 [0.66-2.95],0.3783957427308181
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26496,171,0.60 [0.42-0.84],0.0033216478856891
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,26486,161,0.60 [0.42-0.86],0.0053169000797544
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24827,1648,0.80 [0.71-0.91],0.0003765938391146
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27582,117,0.82 [0.53-1.27],0.3765065295795755
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27586,464,0.73 [0.59-0.90],0.0040239749444926
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26444,710,0.85 [0.71-1.02],0.0846853677650271
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27212,329,0.73 [0.56-0.95],0.0169893284093224
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26954,71,0.85 [0.49-1.48],0.5697800827866262
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27093,210,0.83 [0.60-1.15],0.2641654493949625
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27759,92,1.20 [0.73-1.98],0.463796106192207
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27731,64,1.15 [0.63-2.07],0.650105058077403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27718,51,1.63 [0.84-3.17],0.1492805318481428
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27776,55,0.76 [0.40-1.42],0.3873934644607575
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27773,52,0.80 [0.42-1.53],0.4998775918814553
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27180,58,0.45 [0.25-0.78],0.0045194281154918
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27485,363,0.83 [0.65-1.06],0.1299606076098611
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25840,106,1.20 [0.75-1.91],0.4438812722011953
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25894,160,0.95 [0.65-1.39],0.7893141330912621
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25850,116,0.84 [0.54-1.30],0.4237304854968546
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25995,261,0.86 [0.64-1.15],0.3008018913481931
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25971,237,0.83 [0.61-1.14],0.2522550493848143
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19751,4487,0.86 [0.79-0.93],0.0002734695126252
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21523,2585,0.87 [0.79-0.97],0.0095884761143451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25177,1359,0.86 [0.75-0.98],0.0230232953793928
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19154,216,0.77 [0.56-1.06],0.1071469079171758
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19465,527,0.75 [0.61-0.92],0.0062528671784619
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27458,207,0.76 [0.55-1.05],0.0913840434288482
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27475,189,0.88 [0.63-1.25],0.477724124505775
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20195,1257,0.86 [0.74-0.99],0.0351216676361058
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22955,1257,0.87 [0.76-1.01],0.062864315473617
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18950,12,0.55 [0.15-2.09],0.3839847631135658
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27851,12,0.63 [0.18-2.30],0.4880823293711136
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19221,283,0.85 [0.64-1.13],0.268267079840954
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19028,90,1.18 [0.71-1.95],0.5287477007407464
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19252,314,0.96 [0.73-1.26],0.7623827807351653
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27850,158,1.14 [0.78-1.67],0.4844700431758201
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19433,495,0.95 [0.76-1.18],0.633414323678609
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19434,496,0.73 [0.59-0.90],0.0041926605848703
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20382,1444,1.00 [0.87-1.14],0.9561380370409684
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19047,109,0.85 [0.54-1.35],0.4889321501646959
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19367,429,1.03 [0.81-1.31],0.794707787425436
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,19022,84,0.78 [0.46-1.32],0.3525628645207509
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19045,107,1.02 [0.64-1.62],0.947019267333504
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19316,378,1.07 [0.83-1.37],0.6209988110841029
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19260,322,1.08 [0.82-1.41],0.5835192406998111
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20902,305,1.20 [0.91-1.58],0.203341586060183
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27212,223,0.61 [0.44-0.83],0.0018344089871792
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27083,94,0.47 [0.30-0.75],0.0016121741739904
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24001,85,1.08 [0.64-1.82],0.7619032808459972
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24229,313,0.84 [0.64-1.10],0.2020193157782953
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24968,1052,0.90 [0.78-1.05],0.1828776617342713
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24137,221,0.85 [0.62-1.17],0.327831991227986
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23995,79,0.76 [0.45-1.30],0.3188235896024659
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24753,837,0.86 [0.73-1.01],0.0738974872876322
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23969,53,0.70 [0.37-1.33],0.2765045587872708
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24164,248,0.83 [0.61-1.12],0.2298839927595424
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24021,105,0.59 [0.38-0.93],0.0220617335629995
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24010,94,1.35 [0.82-2.21],0.2337811958244322
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24082,166,1.06 [0.73-1.54],0.7481008915633636
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23993,77,1.06 [0.62-1.83],0.8324448808144892
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24278,362,0.74 [0.58-0.95],0.0186413131407607
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24209,391,0.81 [0.64-1.03],0.0895589291919647
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23894,76,0.70 [0.41-1.19],0.1898874498162996
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23930,112,1.28 [0.81-2.01],0.293080104057144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23963,145,0.67 [0.45-0.99],0.0417284756260291
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23857,39,0.57 [0.28-1.17],0.1277596373822796
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23877,59,0.97 [0.52-1.79],0.9110747411260413
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23861,43,1.12 [0.54-2.31],0.7638993096651578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24101,283,0.86 [0.65-1.14],0.2994785578155134
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23879,61,1.17 [0.64-2.16],0.6049107225151606
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23888,70,0.59 [0.34-1.01],0.0538419085641796
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23960,142,1.07 [0.72-1.60],0.7400959497026403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23901,83,0.82 [0.49-1.38],0.4589956584233853
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24369,551,0.90 [0.73-1.10],0.2979806907075988
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24012,194,0.74 [0.53-1.04],0.0840331944796578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24115,297,1.05 [0.80-1.38],0.7320814471543073
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25255,240,0.89 [0.65-1.20],0.4434515616831342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25508,493,0.91 [0.73-1.12],0.3743485214463322
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25056,41,0.65 [0.32-1.34],0.2456978830792956
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25082,67,1.16 [0.65-2.10],0.6135447666634013
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25133,118,1.16 [0.75-1.81],0.505757404887129
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22888,6224,0.90 [0.83-0.96],0.0022422729109227
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25544,204,0.63 [0.46-0.87],0.0051168796022463
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25385,45,1.08 [0.53-2.21],0.8233044736352565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25720,36,0.63 [0.29-1.35],0.2322854729147145
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25733,49,0.35 [0.20-0.61],0.0002246777577837
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25725,41,0.50 [0.25-1.00],0.050314149078684
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27804,134,1.09 [0.72-1.64],0.6802754616154625
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27682,67,0.82 [0.47-1.45],0.4965618267488919
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27771,101,1.00 [0.63-1.60],0.9985255260375264
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27708,38,1.43 [0.65-3.11],0.3715233081013992
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25784,1275,0.83 [0.72-0.95],0.0066932976570291
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cystitis,24647,138,0.75 [0.51-1.12],0.159073653984854
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24598,89,1.04 [0.63-1.72],0.8878686871904558
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24680,171,0.92 [0.64-1.32],0.6331551904743162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24598,89,0.67 [0.41-1.09],0.1042269999252527
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25514,1005,0.83 [0.72-0.97],0.0198286509784032
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27736,485,1.35 [1.09-1.68],0.0067681942685759
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27401,150,1.60 [1.08-2.36],0.0178529374278748
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27422,171,1.07 [0.74-1.54],0.7268134495943646
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27364,113,1.36 [0.87-2.13],0.1765516265325456
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27673,565,0.93 [0.76-1.14],0.4862835515933624
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27242,134,0.99 [0.66-1.50],0.975403260904376
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27360,252,0.91 [0.68-1.23],0.5476251874339277
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25573,4660,0.93 [0.86-1.00],0.0499119071215435
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Endometriosis,21280,367,1.10 [0.86-1.42],0.4428383326373217
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,21011,98,1.47 [0.90-2.40],0.1196428955499631
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21083,170,0.83 [0.58-1.20],0.3239281693738879
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21719,806,0.79 [0.67-0.93],0.0052759976928488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21330,417,0.91 [0.72-1.15],0.4121877484361455
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21887,974,0.96 [0.82-1.13],0.6356555014154099
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21234,321,1.09 [0.84-1.43],0.5101701661219726
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21359,446,0.88 [0.71-1.11],0.2825504899459053
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,21014,101,1.01 [0.65-1.56],0.967810107971551
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,21104,191,0.61 [0.44-0.86],0.0043650081078977
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",28013,270,0.72 [0.54-0.96],0.024651767344395
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,28025,256,0.73 [0.54-0.97],0.0322808661283566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,28051,142,0.70 [0.47-1.03],0.0685763847906505
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",28040,156,0.71 [0.49-1.03],0.0722242606134462
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21061,148,0.85 [0.58-1.25],0.4129477382968805
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21028,115,0.85 [0.54-1.31],0.4565986289270359
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21058,145,0.97 [0.65-1.44],0.8746024537867773
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Irregular menses,27942,474,0.86 [0.69-1.07],0.1646899055958406
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22277,1364,0.92 [0.81-1.05],0.2298440279936399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21803,890,0.97 [0.83-1.15],0.74644923798486
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",28030,197,0.68 [0.49-0.95],0.0237546612655202
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21387,474,0.84 [0.68-1.05],0.1205720856682776
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21247,334,0.98 [0.75-1.28],0.8768908347380494
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21821,908,1.15 [0.98-1.35],0.0976074555224194
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female infertility,21028,115,1.14 [0.72-1.82],0.5751913648030087
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",21021,108,1.09 [0.68-1.77],0.713709161301981
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,28047,888,1.35 [1.13-1.62],0.0009982809218422
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,28050,1214,1.21 [1.03-1.42],0.0193635106971677
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,28048,487,0.99 [0.79-1.24],0.931888301253892
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27699,138,1.15 [0.76-1.74],0.5082075460772699
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27756,195,0.93 [0.66-1.32],0.7021252513990266
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27731,170,1.03 [0.71-1.49],0.8929131673378154
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",28066,168,1.20 [0.82-1.76],0.3441057043405484
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,28068,165,1.24 [0.84-1.82],0.2798417504522307
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,28066,423,1.02 [0.80-1.31],0.8515520812107877
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27770,127,0.87 [0.57-1.34],0.5380184821234903
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27876,233,1.25 [0.91-1.73],0.1727591535470864
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27308,149,1.69 [1.12-2.55],0.0127829587668391
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27362,203,1.24 [0.87-1.76],0.2272153523292484
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27412,253,0.97 [0.71-1.33],0.8524973076631286
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27307,148,1.32 [0.87-1.99],0.1862866804756732
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27299,140,1.52 [1.00-2.31],0.0491756240491298
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27312,153,1.54 [1.03-2.31],0.0347809213671882
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,27071,235,1.51 [1.08-2.11],0.0161268257643296
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27280,444,1.24 [0.97-1.58],0.0848817168943964
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27515,679,1.24 [1.00-1.52],0.045608917018467
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",28069,173,0.91 [0.62-1.32],0.6100778790675508
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26594,132,1.25 [0.81-1.92],0.314626128186152
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26939,103,1.43 [0.87-2.34],0.1571090082503422
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,28078,346,1.07 [0.82-1.40],0.6152421994455917
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27996,264,1.04 [0.77-1.41],0.8030002344488085
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",28064,257,1.03 [0.75-1.40],0.8586365959157101
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",28054,247,1.05 [0.76-1.44],0.7694359385965933
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27768,45,1.38 [0.68-2.80],0.3687474996602552
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,25105,654,1.00 [0.83-1.21],0.9649483443506556
